4//SEC Filing
Jover Placid 4
Accession 0000950170-24-090326
CIK 0000818686other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:32 AM ET
Size
5.9 KB
Accession
0000950170-24-090326
Insider Transaction Report
Form 4
Jover Placid
See "Remarks"
Transactions
- Award
Restricted Share Units
2024-08-01+51,311→ 51,311 total→ Ordinary Shares (51,311 underlying)
Footnotes (3)
- [F1]Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on August 1, 2024, with 12,827 vesting on each of August 1, 2025, August 1, 2026 and August 1, 2027 and 12,830 vesting on August 1, 2028.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0002026165
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:32 AM ET
- Size
- 5.9 KB